Fig. 4.
Genetic alterations in FAK and FAK mRNA expression in uveal melanoma patients: a Bar graph showing the percentage of alteration of PTK2 (FAK) gene in different types of cancer (cBioportal). b Genetic alterations affecting uveal PTK2 (FAK) in uveal melanoma; 57% of cases presented either genetic or mRNA alterations. The correlation between PTK2 mRNA expression and patients’ overall survival (c) in uveal melanoma patients